Results 281 to 289 of about 1,709,620 (289)
Some of the next articles are maybe not open access.

The Accelerated Approval Program for Cancer Drugs - Finding the Right Balance.

New England Journal of Medicine, 2023
B. Gyawali, A. Kesselheim, Joseph S Ross
semanticscholar   +1 more source

Increasing FDA Accelerated approval of Single-Arm Trials in Oncology (1992 to 2020).

Journal of Clinical Epidemiology, 2023
T. Ribeiro   +5 more
semanticscholar   +1 more source

The On- and Off-Ramps of Oncology Accelerated Approval.

New England Journal of Medicine, 2022
L. Fashoyin-Aje   +3 more
semanticscholar   +1 more source

Sotorasib's Accelerated Approval: Wrong Dose and Indication.

JAMA Oncology
This Viewpoint reviews the accelerated approval process and lack of postapproval studies to verify its benefit as it applied to sotorasib, a treatment for non–small cell lung cancer with the KRASg12c mutation, and recommends measures to ensure ...
M. Ratain, Aaron S. Kesselheim
semanticscholar   +1 more source

Accelerated Approval - Taking the FDA's Concerns Seriously.

New England Journal of Medicine, 2022
R. Sachs, J. Donohue, S. Dusetzina
semanticscholar   +1 more source

Global consequences of the US FDA's accelerated approval of cancer drugs.

The Lancet Oncology, 2022
Amol Akhade, B. Sirohi, B. Gyawali
semanticscholar   +1 more source

Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses.

Molecular Genetics and Metabolism
J. Muenzer   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy